The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 1,670.50
Ask: 1,671.00
Change: 17.00 (1.03%)
Spread: 0.50 (0.03%)
Open: 1,650.00
High: 1,677.00
Low: 1,646.00
Prev. Close: 1,653.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Defensive stocks buoy FTSE 100 before U.S.-China trade deal

Wed, 15th Jan 2020 09:20

* FTSE 100 up 0.3%, FTSE 250 down 0.2%

* U.S. tariffs on China to remain in place for now

* Tullow Oil drags midcaps lower

* Banks drop on rate cut bets
(Adds company news items, updates to closing prices)

By Shashwat Awasthi and Muvija M

Jan 15 (Reuters) - London's main share index rose slightly
on Wednesday, hours before the sealing of an initial U.S.-China
trade deal, though sentiment was tempered when Washington said
tariffs on Chinese goods would not be rolled back immediately.

The FTSE 100 rose 0.3% on a third day of gains,
supported by a host of so-called defensive stocks including
pharmaceutical giants AstraZeneca and GlaxoSmithKline
, which rose nearly 2%, and consumer goods companies.

Investors tend to turn to these sectors at times of
macroeconomic uncertainty.

The FTSE 250 ended 0.2% lower, with a 16% plunge in
Tullow Oil weighing the most. Tullow said it would take
a $1.5 billion writedown after cutting its long-term oil price
assumptions.

Investors betting on a quick de-escalation of Sino-American
tensions were dealt a blow when U.S. Treasury Secretary Steven
Mnuchin said tariffs on Chinese goods would not be repealed
until the completion of a Phase 2 agreement.

"Strategic competition between the U.S. and China,
especially in tech, is likely to persist despite a limited
'Phase 1' trade deal," BlackRock analysts wrote in their weekly
note.

"The U.S.-China trade conflict – 2019's dominant
geopolitical risk – has paused, yet we expect enduring strategic
rivalry between the two countries."

Banks suffered across the board as weak inflation data
further spurred hopes that the Bank of England will cut interest
rates in its January meeting. Low interest rates squeeze a
lender's margins.

Royal Bank of Scotland, which also had its rating
downgraded by Barclays, led the sub-index down 1%
to a one-month low with a 2.5% share price fall.

Keeping a lid on losses on the midcap bourse, Provident
Financial jumped 7% after its key credit card business
enjoyed a better-than-expected fourth quarter and Hochschild
Mining climbed 3% on better-than-expected 2019
production.

Among smaller stocks, fast fashion retailer QUIZ
tanked nearly 20% on its worst day since June, as it pointed to
poor trading over the key Christmas period.
(Reporting by Shashwat Awasthi and Muvija M in Bengaluru,
Editing by Sherry Jacob-Phillips and Shailesh Kuber)

More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.